234 related articles for article (PubMed ID: 26067744)
1. Association between colchicine resistance and vitamin D in familial Mediterranean fever.
Ozer I; Mete T; Turkeli Sezer O; Kolbasi Ozgen G; Kucuk GO; Kaya C; Kilic Kan E; Duman G; Ozturk Kurt HP
Ren Fail; 2015 Aug; 37(7):1122-5. PubMed ID: 26067744
[TBL] [Abstract][Full Text] [Related]
2. Decreased vitamin D levels in children with familial Mediterranean fever.
Anık A; Catlı G; Makay B; Abacı A; Küme T; Unsal E; Böber E
Int J Rheum Dis; 2014 Mar; 17(3):321-6. PubMed ID: 24410734
[TBL] [Abstract][Full Text] [Related]
3. Decreased vitamin D levels in patients with familial mediterranean fever.
Kisacik B; Kaya SU; Pehlivan Y; Tasliyurt T; Sayarlioglu M; Onat AM
Rheumatol Int; 2013 May; 33(5):1355-7. PubMed ID: 22187059
[TBL] [Abstract][Full Text] [Related]
4. Colchicine resistance and low vitamin D in familial Mediterranean fever.
Anık A; Abacı A; Ünsal E; Makay B
Ren Fail; 2016; 38(2):340-1. PubMed ID: 26707648
[No Abstract] [Full Text] [Related]
5. Vitamin D levels in children with familial Mediterranean fever.
Onur H; Aral H; Arica V; Bercem GA; Kasapcopur O
Pediatr Rheumatol Online J; 2016 Apr; 14(1):28. PubMed ID: 27121284
[TBL] [Abstract][Full Text] [Related]
6. Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial.
Ben-Zvi I; Livneh A
Isr Med Assoc J; 2014 May; 16(5):271-3. PubMed ID: 24979828
[TBL] [Abstract][Full Text] [Related]
7. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
8. Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine.
Rozenbaum M; Boulman N; Feld J; Avshovich N; Petrovich S; Elias M; Slobodin G; Rosner I
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S105. PubMed ID: 19796546
[No Abstract] [Full Text] [Related]
9. Diagnostic validity of colchicine in patients with Familial Mediterranean fever.
Ozaltin F; Bilginer Y; Gülhan B; Bajin I; Erdogan O; Hayran M; Yılmaz E; Ozen S
Clin Rheumatol; 2014 Jul; 33(7):969-74. PubMed ID: 24740462
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of polymyositis and familial Mediterranean fever.
Eguchi M; Miyashita T; Shirouzu H; Sato S; Izumi Y; Takeoka A; Ohno T; Sumiyoshi R; Nishino A; Jiuchi Y; Nonaka F; Eguchi K; Kawakami A; Migita K
Mod Rheumatol; 2013 Mar; 23(2):374-8. PubMed ID: 22534884
[TBL] [Abstract][Full Text] [Related]
11. Can colchicine response be predicted in familial Mediterranean fever patients?
Özçakar ZB; Elhan AH; Yalçınkaya F
Rheumatology (Oxford); 2014 Oct; 53(10):1767-72. PubMed ID: 24764265
[TBL] [Abstract][Full Text] [Related]
12. Plasma and platelet serotonin levels in familial Mediterranean fever.
Onat AM; Ozçakar L; Oztürk MA; Uçar G; Ureten K; Dagli N; Kiraz S; Ertenli I; Calgüneri M
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S16-20. PubMed ID: 17949546
[TBL] [Abstract][Full Text] [Related]
13. Prevention of amyloidosis in familial Mediterranean fever with colchicine: a case-control study in Armenia.
Sevoyan MK; Sarkisian TF; Beglaryan AA; Shahsuvaryan GR; Armenian HK
Med Princ Pract; 2009; 18(6):441-6. PubMed ID: 19797919
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
Kallinich T; Wittkowski H; Keitzer R; Roth J; Foell D
Ann Rheum Dis; 2010 Apr; 69(4):677-82. PubMed ID: 19762364
[TBL] [Abstract][Full Text] [Related]
15. Familial Mediterranean fever without MEFV mutations: a case-control study.
Ben-Zvi I; Herskovizh C; Kukuy O; Kassel Y; Grossman C; Livneh A
Orphanet J Rare Dis; 2015 Mar; 10():34. PubMed ID: 25887307
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine.
Gemici AI; Sevindik ÖG; Akar S; Tunca M
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):57-9. PubMed ID: 24064015
[TBL] [Abstract][Full Text] [Related]
17. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H
Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083
[TBL] [Abstract][Full Text] [Related]
18. Relationship between response to colchicine treatment and MDR1 polymorphism in familial Mediterranean fever patients.
Uludag A; Silan C; Atik S; Akurut C; Uludag A; Silan F; Ozdemir O
Genet Test Mol Biomarkers; 2014 Feb; 18(2):73-6. PubMed ID: 24180297
[TBL] [Abstract][Full Text] [Related]
19. Incomplete response to colchicine in M694V homozygote FMF patients.
Lidar M; Yonath H; Shechter N; Sikron F; Sadetzki S; Langevitz P; Livneh A; Pras E
Autoimmun Rev; 2012 Nov; 12(1):72-6. PubMed ID: 22884555
[TBL] [Abstract][Full Text] [Related]
20. Familial Mediterranean fever.
Onen F
Rheumatol Int; 2006 Apr; 26(6):489-96. PubMed ID: 16283319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
